Diabetes insipidus, nephrogenic, X-linked: genes and variants
Explore variant evidence for Diabetes insipidus, nephrogenic, X-linked across 1 analyzed protein (AVPR2). Linked ClinVar records include 25 pathogenic or likely pathogenic variants, 25 variants of uncertain significance and 11 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Diabetes insipidus, nephrogenic, X-linked
AVPR2: Vasopressin V2 receptor
A vasopressin receptor in kidney collecting-duct cells that activates cAMP signaling and promotes insertion of aquaporin-2 water channels. Pathogenic variants can cause X-linked nephrogenic diabetes insipidus.
25 ClinVar pathogenic / likely pathogenic and 36 uncertain variants in AVPR2 have source records linked to Diabetes insipidus, nephrogenic, X-linked. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Diabetes insipidus, nephrogenic, X-linked
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| AVPR2 R202C | 202 | Transmembrane | Pathogenic / likely pathogenic (★★★★) |
| AVPR2 R104C | 104 | Extracellular | Pathogenic / likely pathogenic (★★) |
| AVPR2 G107E | 107 | Extracellular | Pathogenic / likely pathogenic (★★) |
| AVPR2 S171R | 171 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| AVPR2 L44F | 44 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| AVPR2 V88M | 88 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| AVPR2 R113W | 113 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| AVPR2 Y128S | 128 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| AVPR2 S167L | 167 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| AVPR2 R181C | 181 | Extracellular | Pathogenic / likely pathogenic (★★) |
| AVPR2 Q174H | 174 | Transmembrane | Pathogenic / likely pathogenic (★) |
| AVPR2 M272I | 272 | Transmembrane | Pathogenic / likely pathogenic (★) |
| AVPR2 Q174E | 174 | Transmembrane | Pathogenic / likely pathogenic (★) |
| AVPR2 T273M | 273 | Transmembrane | Pathogenic / likely pathogenic (★) |
| AVPR2 R203C | 203 | Transmembrane | Pathogenic / likely pathogenic (★) |
| AVPR2 F287L | 287 | Transmembrane | Pathogenic / likely pathogenic (★) |
| AVPR2 P322S | 322 | Transmembrane | Pathogenic / likely pathogenic (★) |
| AVPR2 M272V | 272 | Transmembrane | Pathogenic / likely pathogenic |
| AVPR2 F105V | 105 | Extracellular | Pathogenic / likely pathogenic |
| AVPR2 I130F | 130 | Transmembrane | Pathogenic / likely pathogenic |
| AVPR2 G201D | 201 | Transmembrane | Pathogenic / likely pathogenic |
| AVPR2 I46K | 46 | Transmembrane | Pathogenic / likely pathogenic |
| AVPR2 C112F | 112 | Transmembrane | Pathogenic / likely pathogenic |
| AVPR2 A132D | 132 | Transmembrane | Pathogenic / likely pathogenic |
| AVPR2 G185C | 185 | Extracellular | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Diabetes insipidus, nephrogenic, X-linked
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| AVPR2 C112Y | 112 | Transmembrane | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; C112F at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| AVPR2 C112R | 112 | Transmembrane | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; C112F at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.98 |
Which prediction tools work for Diabetes insipidus, nephrogenic, X-linked
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- AlphaMissense: 100 out of 100
- MutPred: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 98 out of 100
- PolyPhen-2: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 85 out of 100
- MetaLR: 79 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Nephrogenic diabetes insipidus also has ClinVar records linked to AVPR2 variants; they fall partly in the same places as the Diabetes insipidus, nephrogenic, X-linked variants (7 pathogenic / likely pathogenic).
Diseases related to Diabetes insipidus, nephrogenic, X-linked
- Nephrogenic diabetes insipidus, also linked to AVPR2
- Renal tubulopathies, also linked to AVPR2
- Autosomal dominant polycystic kidney disease, also linked to AVPR2
- Nephrogenic syndrome of inappropriate antidiuresis, also linked to AVPR2
Frequently asked questions
Which genes have records linked to Diabetes insipidus, nephrogenic, X-linked?
This view contains 1 analyzed proteins: AVPR2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 25 pathogenic or likely pathogenic variants, 25 variants of uncertain significance and 11 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 2 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 76 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center